Oxford vaccine approved for import and use in Bangladesh

The Department of Drug Administration has approved the import and emergency use of the coronavirus vaccine invented by Oxford University in the United Kingdom.

Deputy Director and spokesman of the department. Ayub Hossain told Prothom Alo that the use of Oxford and AstraZeneca vaccines has been approved. He said the approval was given in response to Beximco’s application. Registration is a long process. For this reason, NOC (No Objection Certificate) has been issued after the application of Beximco.

This approval was required to bring and use the Oxford vaccine in Bangladesh. The government, pharmaceutical company Beximco and Seram Institute have already reached an agreement with Seram Institute of India to buy 30 million doses of vaccine.

Beximco Managing Director (MD) Nazmul Hasan told reporters at his residence in Gulshan today that the vaccine would be brought to the country from India within 30 days after the drug administration approves and registers its use in Bangladesh. He said they submitted all kinds of documents for registration last Thursday. The bank has conveyed the guarantee to the government.

Many, including the government’s health minister, have said the coronavirus vaccine will arrive in the country by the end of this month or early February.

However, the Seram Institute said that the government has not yet given permission for the export of vaccines from India. After their statement, various discussions started. However, Foreign Minister AK Abdul Momen, Health Secretary Abdul Mannan and a spokesman for Beximco told the media at various times today that there was no problem in getting vaccines in Bangladesh.

Health Minister Zahid Malek said it would not be a problem to get vaccinated, adding, “I have confidence in our long-standing friendship with India.”

Leave a Comment